Sarcopenic obesity using the ESPEN and EASO consensus statement criteria of 2022 – Results from the German KORA-Age study

The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to...

Full description

Saved in:
Bibliographic Details
Published in:Obesity Research & Clinical Practice Vol. 17; no. 4; pp. 349 - 352
Main Authors: Schluessel, Sabine, Huemer, Marie-Theres, Peters, Annette, Drey, Michael, Thorand, Barbara
Format: Journal Article
Language:English
Japanese
Published: Elsevier Ltd 01.07.2023
Elsevier BV
Subjects:
ISSN:1871-403X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits. The KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis. The overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84–4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23–5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05–3.63]), cognitive impairment (3.03 [CI 1.51–6.06]) and arthritis (2.66 [CI 1.39–5.07]) after adjusting for age, sex and marital status. Sarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal.
AbstractList The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits.OBJECTIVEThe recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits.The KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis.METHODSThe KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis.The overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84-4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23-5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05-3.63]), cognitive impairment (3.03 [CI 1.51-6.06]) and arthritis (2.66 [CI 1.39-5.07]) after adjusting for age, sex and marital status.RESULTSThe overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84-4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23-5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05-3.63]), cognitive impairment (3.03 [CI 1.51-6.06]) and arthritis (2.66 [CI 1.39-5.07]) after adjusting for age, sex and marital status.Sarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal.CONCLUSIONSarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal.
The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits. The KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis. The overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84–4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23–5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05–3.63]), cognitive impairment (3.03 [CI 1.51–6.06]) and arthritis (2.66 [CI 1.39–5.07]) after adjusting for age, sex and marital status. Sarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal.
Author Schluessel, Sabine
Huemer, Marie-Theres
Drey, Michael
Peters, Annette
Thorand, Barbara
Author_xml – sequence: 1
  givenname: Sabine
  orcidid: 0000-0002-2485-8859
  surname: Schluessel
  fullname: Schluessel, Sabine
  email: Sabine.Schluessel@med.uni-muenchen.de
  organization: Department of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336 Munich, Germany
– sequence: 2
  givenname: Marie-Theres
  surname: Huemer
  fullname: Huemer, Marie-Theres
  organization: Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany
– sequence: 3
  givenname: Annette
  surname: Peters
  fullname: Peters, Annette
  organization: Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany
– sequence: 4
  givenname: Michael
  surname: Drey
  fullname: Drey, Michael
  organization: Department of Medicine IV, University Hospital, Ludwig Maximilian University Munich, Ziemssenstraße 5, 80336 Munich, Germany
– sequence: 5
  givenname: Barbara
  surname: Thorand
  fullname: Thorand, Barbara
  organization: Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany
BackLink https://cir.nii.ac.jp/crid/1873679867828052608$$DView record in CiNii
BookMark eNp9kctu1DAUhr0oEm3hBbryggWbBF-S2GE3qoZSUTGoQyV2luOcFA-JPdgO0ohN34E35ElwOqy66OZ483_n8vkMnTjvAKELSkpKaPNuV_pg9iUjjJdEloSwE3RKpaBFRfi3l-gsxh0hdd1W_BT93upg_B6cNdh3EG064Dlad4_Td8Dr7Zf1Z6xdj9er7QYb7yK4OEcck04wgUvYBJsgWI39gPNIhv8-_MG3EOcxRTwEPz02uoIwaYc_bW5XxeoeMj_3h1foxaDHCK__v-fo7sP66-XH4mZzdX25uilMxZpU9J2sOK11y7uO045JAgMB2lPBddVqSqFjnRCsGYQgvKXDQDpaNTWtmAAwhp-jt8e---B_zhCTmmw0MI7agZ-jYrIWsmo5kznKjlETfIwBBrUPdtLhoChRi121U4tdtdhVRKpsN0PyCWRs9mO9S0Hb8Xn0zRF11mZqqfmneCNa2QiZT61ZQ5a13h9jkDX9shCUGXPY6PEHHFTv7XMz_gHVxqNT
CitedBy_id crossref_primary_10_1016_j_ejso_2024_108772
crossref_primary_10_1007_s13679_024_00571_2
crossref_primary_10_3390_jcm13102880
crossref_primary_10_1002_jcsm_13821
crossref_primary_10_1016_j_archger_2024_105557
crossref_primary_10_1016_j_archger_2024_105444
crossref_primary_10_1016_j_clnesp_2024_08_017
crossref_primary_10_1016_j_tjfa_2025_100072
crossref_primary_10_1097_MCO_0000000000001062
crossref_primary_10_3389_fnut_2025_1575580
crossref_primary_10_1001_jamanetworkopen_2024_17115
crossref_primary_10_1186_s12877_025_05897_7
crossref_primary_10_3390_jcm13226685
crossref_primary_10_1002_oby_24157
crossref_primary_10_1111_eci_70059
crossref_primary_10_1111_obr_70005
crossref_primary_10_1016_j_clnesp_2025_05_033
crossref_primary_10_1111_nbu_12725
crossref_primary_10_1186_s12877_024_04952_z
crossref_primary_10_1186_s12877_024_04955_w
Cites_doi 10.1007/s00198-017-4027-y
10.1016/j.mad.2022.111728
10.1159/000521241
10.1371/journal.pone.0256702
10.1016/j.nut.2019.05.006
10.1007/s00391-011-0245-7
10.1016/j.clnu.2022.03.017
10.1093/ajcn/72.3.694
10.1016/j.clnu.2021.06.009
10.3390/nu14194205
10.1016/j.jamda.2023.03.008
10.1093/ageing/afy169
10.1046/j.1532-5415.2002.50216.x
10.1007/s12603-018-1088-3
ContentType Journal Article
Copyright 2023
Copyright © 2023. Published by Elsevier Ltd.
Copyright_xml – notice: 2023
– notice: Copyright © 2023. Published by Elsevier Ltd.
DBID RYH
AAYXX
CITATION
7X8
DOI 10.1016/j.orcp.2023.08.002
DatabaseName CiNii Complete
CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 352
ExternalDocumentID 10_1016_j_orcp_2023_08_002
S1871403X23000674
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
123
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5VS
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OB0
ON-
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SDF
SDG
SEL
SES
SPCBC
SSH
SSZ
T5K
UNMZH
Z5R
~G-
~HD
RYH
9DU
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c426t-db84315a93bb31b280ef0e1d173a49a11eb2b7726f770391ff0b14651427eecc3
ISICitedReferencesCount 22
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001078691000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1871-403X
IngestDate Sun Sep 28 06:18:59 EDT 2025
Sat Nov 29 07:00:24 EST 2025
Tue Nov 18 21:49:37 EST 2025
Mon Nov 10 09:17:11 EST 2025
Tue Oct 14 19:31:12 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Prevalence
Skeletal muscle mass
Handgrip strength
Fat mass
SMM/W
Multimorbidity
Sarcopenic obesity
Disability
Bioelectrical impedance analysis
Polypharmacy
Aging population
BIA
SO
TICS-m
BMI
WHO
Cognitive impairment
Language English
Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c426t-db84315a93bb31b280ef0e1d173a49a11eb2b7726f770391ff0b14651427eecc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2485-8859
0000-0002-4329-8607
PQID 2857849328
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_2857849328
crossref_primary_10_1016_j_orcp_2023_08_002
crossref_citationtrail_10_1016_j_orcp_2023_08_002
nii_cinii_1873679867828052608
elsevier_clinicalkey_doi_10_1016_j_orcp_2023_08_002
PublicationCentury 2000
PublicationDate July-August 2023
2023-07-01
2023-07-00
20230701
PublicationDateYYYYMMDD 2023-07-01
PublicationDate_xml – month: 07
  year: 2023
  text: July-August 2023
PublicationDecade 2020
PublicationTitle Obesity Research & Clinical Practice
PublicationYear 2023
Publisher Elsevier Ltd
Elsevier BV
Publisher_xml – name: Elsevier Ltd
– name: Elsevier BV
References Janssen, Heymsfield, Ross (bib8) 2002; 50
Yoshimura, Wakabayashi, Nagano, Matsumoto, Shimazu, Shiraishi (bib13) 2022; 14
Peters, Döring, Ladwig, Meisinger, Linkohr, Autenrieth (bib7) 2011; 44 Suppl 2
Shimizu, Maeda, Ueshima, Inoue, Murotani, Ohno (bib12) 2022; 208
Morikawa, Lee, Makino, Harada, Katayama, Tomida (bib14) 2023
Tou, Wee, Pang, Lau, Jabbar, Seah (bib17) 2021; 16
Gallagher, Heymsfield, Heo, Jebb, Murgatroyd, Sakamoto (bib9) 2000; 72
Donini, Busetto, Bischoff, Cederholm, Ballesteros-Pomar, Batsis (bib5) 2022; 15
Phillips, Strobl, Vogt, Ladwig, Thorand, Grill (bib6) 2017; 28
Someya, Tamura, Kaga, Sugimoto, Kadowaki, Suzuki (bib16) 2022; 41
Wang, Hai, Liu, Cao, Liu, Liu (bib15) 2019; 23
Gupta, Fonarow, Horwich (bib2) 2015; 31
Anon (bib3) 2000; 894
Wei, Nyunt, Gao, Wee, Ng (bib1) 2019; 66
Statistisches Bundesamt. Statistical yearbook 2010 for the Federal Republic of Germany including “International tables” (German). Wiesbaden: Statistisches Bundesamt (Federal Statistical Office).
Gao, Mei, Shang, Hu, Chen, Zhao (bib11) 2021; 40
Cruz-Jentoft, Bahat, Bauer, Boirie, Bruyère, Cederholm (bib4) 2019; 48
10.1016/j.orcp.2023.08.002_bib10
Tou (10.1016/j.orcp.2023.08.002_bib17) 2021; 16
Phillips (10.1016/j.orcp.2023.08.002_bib6) 2017; 28
Yoshimura (10.1016/j.orcp.2023.08.002_bib13) 2022; 14
Anon (10.1016/j.orcp.2023.08.002_bib3) 2000; 894
Janssen (10.1016/j.orcp.2023.08.002_bib8) 2002; 50
Wei (10.1016/j.orcp.2023.08.002_bib1) 2019; 66
Gupta (10.1016/j.orcp.2023.08.002_bib2) 2015; 31
Donini (10.1016/j.orcp.2023.08.002_bib5) 2022; 15
Cruz-Jentoft (10.1016/j.orcp.2023.08.002_bib4) 2019; 48
Gao (10.1016/j.orcp.2023.08.002_bib11) 2021; 40
Wang (10.1016/j.orcp.2023.08.002_bib15) 2019; 23
Someya (10.1016/j.orcp.2023.08.002_bib16) 2022; 41
Morikawa (10.1016/j.orcp.2023.08.002_bib14) 2023
Gallagher (10.1016/j.orcp.2023.08.002_bib9) 2000; 72
Peters (10.1016/j.orcp.2023.08.002_bib7) 2011; 44 Suppl 2
Shimizu (10.1016/j.orcp.2023.08.002_bib12) 2022; 208
References_xml – volume: 41
  start-page: 1046
  year: 2022
  end-page: 1051
  ident: bib16
  article-title: Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: the Bunkyo health study
  publication-title: Clin Nutr
– reference: Statistisches Bundesamt. Statistical yearbook 2010 for the Federal Republic of Germany including “International tables” (German). Wiesbaden: Statistisches Bundesamt (Federal Statistical Office).
– volume: 40
  start-page: 4633
  year: 2021
  end-page: 4641
  ident: bib11
  article-title: Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis
  publication-title: Clin Nutr
– volume: 14
  year: 2022
  ident: bib13
  article-title: The applicability of the ESPEN and EASO-defined diagnostic criteria for sarcopenic obesity in Japanese patients after stroke: prevalence and association with outcomes
  publication-title: Nutrients
– volume: 208
  year: 2022
  ident: bib12
  article-title: Prevalence of sarcopenic obesity based on newly proposed diagnostic criteria and functional outcomes in older adults undergoing rehabilitation
  publication-title: Mech Ageing Dev
– volume: 44 Suppl 2
  start-page: 41
  year: 2011
  end-page: 54
  ident: bib7
  article-title: Multimorbidity and successful aging: the population-based KORA-Age study
  publication-title: Z Gerontol Geriatr
– year: 2023
  ident: bib14
  article-title: Sarcopenic obesity and risk of disability in community-dwelling Japanese older adults: a 5-year longitudinal study
  publication-title: J Am Med Dir Assoc
– volume: 72
  start-page: 694
  year: 2000
  end-page: 701
  ident: bib9
  article-title: Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index
  publication-title: Am J Clin Nutr
– volume: 28
  start-page: 2069
  year: 2017
  end-page: 2079
  ident: bib6
  article-title: Sarcopenia is associated with disability status-results from the KORA-Age study
  publication-title: Osteoporos Int
– volume: 50
  start-page: 889
  year: 2002
  end-page: 896
  ident: bib8
  article-title: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability
  publication-title: J Am Geriatr Soc
– volume: 48
  start-page: 16
  year: 2019
  end-page: 31
  ident: bib4
  article-title: Sarcopenia: revised European consensus on definition and diagnosis
  publication-title: Age Ageing
– volume: 66
  start-page: 180
  year: 2019
  end-page: 186
  ident: bib1
  article-title: Long-term changes in nutritional status are associated with functional and mortality outcomes among community-living older adults
  publication-title: Nutrition
– volume: 894
  start-page: 1
  year: 2000
  end-page: 253
  ident: bib3
  article-title: Obesity: preventing and managing the global epidemic. Report of a WHO consultation
  publication-title: World Health Organ Tech Rep Ser
– volume: 15
  start-page: 321
  year: 2022
  end-page: 335
  ident: bib5
  article-title: Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
  publication-title: Obes Facts
– volume: 23
  start-page: 14
  year: 2019
  end-page: 20
  ident: bib15
  article-title: Associations between sarcopenic obesity and cognitive impairment in elderly Chinese community-dwelling individuals
  publication-title: J Nutr Health Aging
– volume: 31
  start-page: 195
  year: 2015
  end-page: 202
  ident: bib2
  article-title: Obesity and the obesity paradox in heart failure
  publication-title: Can J Cardiol
– volume: 16
  year: 2021
  ident: bib17
  article-title: Associations of fat mass and muscle function but not lean mass with cognitive impairment: the Yishun study
  publication-title: PLoS One
– volume: 28
  start-page: 2069
  issue: 7
  year: 2017
  ident: 10.1016/j.orcp.2023.08.002_bib6
  article-title: Sarcopenia is associated with disability status-results from the KORA-Age study
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-017-4027-y
– volume: 208
  year: 2022
  ident: 10.1016/j.orcp.2023.08.002_bib12
  article-title: Prevalence of sarcopenic obesity based on newly proposed diagnostic criteria and functional outcomes in older adults undergoing rehabilitation
  publication-title: Mech Ageing Dev
  doi: 10.1016/j.mad.2022.111728
– volume: 31
  start-page: 195
  issue: 2
  year: 2015
  ident: 10.1016/j.orcp.2023.08.002_bib2
  article-title: Obesity and the obesity paradox in heart failure
  publication-title: Can J Cardiol
– volume: 15
  start-page: 321
  issue: 3
  year: 2022
  ident: 10.1016/j.orcp.2023.08.002_bib5
  article-title: Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
  publication-title: Obes Facts
  doi: 10.1159/000521241
– ident: 10.1016/j.orcp.2023.08.002_bib10
– volume: 16
  issue: 8
  year: 2021
  ident: 10.1016/j.orcp.2023.08.002_bib17
  article-title: Associations of fat mass and muscle function but not lean mass with cognitive impairment: the Yishun study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0256702
– volume: 66
  start-page: 180
  year: 2019
  ident: 10.1016/j.orcp.2023.08.002_bib1
  article-title: Long-term changes in nutritional status are associated with functional and mortality outcomes among community-living older adults
  publication-title: Nutrition
  doi: 10.1016/j.nut.2019.05.006
– volume: 44 Suppl 2
  start-page: 41
  year: 2011
  ident: 10.1016/j.orcp.2023.08.002_bib7
  article-title: Multimorbidity and successful aging: the population-based KORA-Age study
  publication-title: Z Gerontol Geriatr
  doi: 10.1007/s00391-011-0245-7
– volume: 41
  start-page: 1046
  issue: 5
  year: 2022
  ident: 10.1016/j.orcp.2023.08.002_bib16
  article-title: Sarcopenic obesity is associated with cognitive impairment in community-dwelling older adults: the Bunkyo health study
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2022.03.017
– volume: 72
  start-page: 694
  issue: 3
  year: 2000
  ident: 10.1016/j.orcp.2023.08.002_bib9
  article-title: Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/72.3.694
– volume: 40
  start-page: 4633
  issue: 7
  year: 2021
  ident: 10.1016/j.orcp.2023.08.002_bib11
  article-title: Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2021.06.009
– volume: 14
  issue: 19
  year: 2022
  ident: 10.1016/j.orcp.2023.08.002_bib13
  article-title: The applicability of the ESPEN and EASO-defined diagnostic criteria for sarcopenic obesity in Japanese patients after stroke: prevalence and association with outcomes
  publication-title: Nutrients
  doi: 10.3390/nu14194205
– year: 2023
  ident: 10.1016/j.orcp.2023.08.002_bib14
  article-title: Sarcopenic obesity and risk of disability in community-dwelling Japanese older adults: a 5-year longitudinal study
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2023.03.008
– volume: 48
  start-page: 16
  issue: 1
  year: 2019
  ident: 10.1016/j.orcp.2023.08.002_bib4
  article-title: Sarcopenia: revised European consensus on definition and diagnosis
  publication-title: Age Ageing
  doi: 10.1093/ageing/afy169
– volume: 50
  start-page: 889
  issue: 5
  year: 2002
  ident: 10.1016/j.orcp.2023.08.002_bib8
  article-title: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability
  publication-title: J Am Geriatr Soc
  doi: 10.1046/j.1532-5415.2002.50216.x
– volume: 894
  start-page: 1
  issue: i–xii
  year: 2000
  ident: 10.1016/j.orcp.2023.08.002_bib3
  article-title: Obesity: preventing and managing the global epidemic. Report of a WHO consultation
  publication-title: World Health Organ Tech Rep Ser
– volume: 23
  start-page: 14
  issue: 1
  year: 2019
  ident: 10.1016/j.orcp.2023.08.002_bib15
  article-title: Associations between sarcopenic obesity and cognitive impairment in elderly Chinese community-dwelling individuals
  publication-title: J Nutr Health Aging
  doi: 10.1007/s12603-018-1088-3
SSID ssj0055943
Score 2.3910692
Snippet The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new...
SourceID proquest
crossref
nii
elsevier
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 349
SubjectTerms Aging population
Bioelectrical impedance analysis
Cognitive impairment
Disability
Fat mass
Handgrip strength
Multimorbidity
Polypharmacy
Prevalence
Sarcopenic obesity
Skeletal muscle mass
Title Sarcopenic obesity using the ESPEN and EASO consensus statement criteria of 2022 – Results from the German KORA-Age study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1871403X23000674
https://cir.nii.ac.jp/crid/1873679867828052608
https://www.proquest.com/docview/2857849328
Volume 17
WOSCitedRecordID wos001078691000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  issn: 1871-403X
  databaseCode: AIEXJ
  dateStart: 20070101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.sciencedirect.com
  omitProxy: false
  ssIdentifier: ssj0055943
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NattAEF4cp5ReSn-p2yZsoTehYO0q0upoWrdpS5xQp-Cb0EqrxsHIwbJCoJe-Qx-s79An6cz-SCYhoTn0shjhXSTNp_nZnZmPkLdMhqVMCuWzMi_8UAnuyww7I4K9ESX4qJmUmmwinkzEbJYc93q_XS3MxSKuKnF5mZz_V1HDNRA2ls7eQdztonABfoPQYQSxw_hPgp_C8yAn1jz3lqbrv9fUrihqPD0eT_SBwXg0PcKc8xq5LmpPFxbpxABQI9i_OUM3koHt9Vw-BMe9_maxrrualI-o1yvvy9HXkT_6vtms1vq7lnfAsz2FTjXS2mpMV6LVnQadLhpsZr4wm9Vy49D_oFGW6OUQw3sf8L3q8h91mrEhVsY6o3U77f3K7MlvlgfYTQ7G24RYp5chroNQV1MHd4o73gBouKGFuemCag06Ny1yr9kKs21xtrdc5di4lPE9k1fbWUaXDXDFYLZpjC5D7izFNVJcI0VST2xuus3i_UT0yfbo03j22TkHEL-Zmg_3PLaOy6QcXr2Tm3ylrWo-v-Y7aIfo5BF5aCMZOjIIfEx6qnpC7h_aXI2n5EcHRGqBSDUQKSCHaiBSACJFINIWiLQFInVApMuSIhDpn5-_qIUgRQjqhQwEqYMg1RB8Rr59GJ-8O_At1Yefg4u49gspwJPdzxIuJQ8kE0NVDlVQBDHPwiQLAiWZhEAwKuMYOQ3KcijBxoO3z2IFWog_J_1qWakXhELMX-RxJAOZl2EoEylFlAVRJIuEFZlQAxK4l5rmtg8-0rEs0pvFOSBeO-fcdIG59d_cySp1XxRY5BSAd-usHRAr3BKOgA-O56PgSjIkHYmGYkDeOIGnYALwXC-r1LKpUybA7IYQiImXd7rPV-RB9629Jv31qlE75F5-sZ7Xq12yFc_ErsXvX2Ds02Q
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sarcopenic+obesity+using+the+ESPEN+and+EASO+consensus+statement+criteria+of+2022+%E2%80%93+Results+from+the+German+KORA-Age+study&rft.jtitle=Obesity+research+%26+clinical+practice&rft.au=Schluessel%2C+Sabine&rft.au=Huemer%2C+Marie-Theres&rft.au=Peters%2C+Annette&rft.au=Drey%2C+Michael&rft.date=2023-07-01&rft.issn=1871-403X&rft.volume=17&rft.issue=4&rft.spage=349&rft.epage=352&rft_id=info:doi/10.1016%2Fj.orcp.2023.08.002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_orcp_2023_08_002
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1871-403X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1871-403X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1871-403X&client=summon